We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Summit Therapeutics Plc | LSE:SUMM | London | Ordinary Share | GB00BN40HZ01 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.50 | 18.00 | 23.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
04/10/2016 12:46 | posted on lse thread: mathsprof Posts: 2,165 Off Topic Opinion: No Opinion Price: 187.50 LTHToday 12:40Well done all who have held through tick and thin. I was pleased to invest in 2011 at just under 8p with a lot of hype at the time . . . Now its all come good. I hope to see 19.5p (old money) again soon - now its £3.90 . . . | pre | |
04/10/2016 12:45 | 100% up today possible!! significant news!!! | miahkaysor | |
04/10/2016 12:40 | Love to AlgernonHow do you know I like tennis?!! | patviera | |
04/10/2016 12:37 | Good man,we shall have a game of tennis followed by coffee and a beer one day. | algernon2 | |
04/10/2016 12:36 | AlgernonI eat humble pieI got it 100pct wrong!!Was convinced a low price placing was on wayDelighted for all holders And hopefully we can find a cure!! | patviera | |
04/10/2016 12:26 | So long as this wonderful news doesn't tie us to Sarpeta's potential disaster fi the FDA later have issue with eteplirsen. Is this all good in the LONG term? | hugus maximus | |
04/10/2016 12:26 | All will want a slice of this now!!! | joeblogg2 | |
04/10/2016 12:25 | Nice to see You surprised Pat! Well done Summ Came out of Left field a bit but exciting nonetheless. | algernon2 | |
04/10/2016 12:24 | Double and more, fantastic news!!! | joeblogg2 | |
04/10/2016 12:23 | Wow Great great great newsI'm nicely surprised!! | patviera | |
04/10/2016 12:19 | I'd like to see the next broker note and the price target! More RDZ news soon as well (presenting at event at end of Oct in US). It could double on Nasdaq this afternoon. | waterloo01 | |
04/10/2016 12:14 | Cashed up till end 2018. I will have to find a way to like SRPT! | waterloo01 | |
04/10/2016 12:09 | GWR7 - 23 Sep 2016 - 13:24:47 - 21102 of 21314 At long last the ducks are lined up. Quack, Quack! | gwr7 | |
04/10/2016 12:08 | Oo-er .... is this a good idea???? PLEASE NO SAREPTA SHARE INVOLVEMENT AT THE END OF ALL THIS?????? | hugus maximus | |
04/10/2016 12:08 | Plus $22m when trial 1st dose (soon) and we keep US rights! | waterloo01 | |
04/10/2016 12:06 | That's set them alight! | godolphin | |
04/10/2016 12:05 | wow indeed. $40m upfront. Guess we can go alone on RDZ! | waterloo01 | |
04/10/2016 11:30 | "Whenever I have any doubts about the likely clinical benefit I go back and reread the MDX papers" I can still see the image of that mouse clinging on !! Which is why I am in SUMM and not SRPT and hope to be vindicated one day. | luminoso | |
04/10/2016 10:56 | Thanks freedosh .. so that's an interesting addition to the scenario. I assume your knowledge of so much of this the process re: anti-inflammatory and something to increase nitrous oxide, might be something that Summit will be aware of and eventually be taken up in practise if efficacy can be shown? | hugus maximus | |
04/10/2016 10:42 | Spot on Hugus. Whenever I have any doubts about the likely clinical benefit I go back and reread the MDX papers IMO there is a high probability of clinical efficacy perhaps, ultimately, in combination with an anti inflammatory and a little blue pill to increase nitrous oxide. | freedosh |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions